<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B936D768-A528-4ABB-A6FA-D5F91D6FD0F4"><gtr:id>B936D768-A528-4ABB-A6FA-D5F91D6FD0F4</gtr:id><gtr:name>Defence Science &amp; Technology Laboratory (DSTL)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Biosciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B936D768-A528-4ABB-A6FA-D5F91D6FD0F4"><gtr:id>B936D768-A528-4ABB-A6FA-D5F91D6FD0F4</gtr:id><gtr:name>Defence Science &amp; Technology Laboratory (DSTL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A3F7EA78-4002-4424-B84B-B0EB7620A591"><gtr:id>A3F7EA78-4002-4424-B84B-B0EB7620A591</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Rodger</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C3A5063-FB4F-41C8-8C74-F1C3BEDF80CB"><gtr:id>6C3A5063-FB4F-41C8-8C74-F1C3BEDF80CB</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:surname>Dafforn</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG005869%2F1"><gtr:id>E5C3E855-EB7B-4E2E-9F69-9DEFB10AB65B</gtr:id><gtr:title>Rapid and simple clinical assays using nanoscale phage-based detectors and linear dichroism spectroscopy.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G005869/1</gtr:grantReference><gtr:abstractText>Much of the work carried out today in clinical medicine involves measuring chemicals in a variety of samples. For example, measurement of hormone levels is an important part of monitoring a number of clinical conditions including infertility. In addition, infection control (particularly for problem pathogens such as MRSA and C. Difficile) involves constant monitoring of patients before, during and after visit to hospital. Much of this monitoring is carried out by skilled scientist in laboratories in hospitals, using complex tests using specially developed antibody reagents. This is not ideally suited to situations where a rapid response may be required. For instance when a GP requires a test for a certain hormone to be carried out, a sample has to be taken by the GP, sent to the hospital, where the test is done (typically taking a number of hours) and results sent to the GP. This leads to delays in diagnosis which lead to and increase the likelihood for a negative outcome for the patient. Our work aims to greatly simplify and speed up the assays currently used in clinical medicine. We plan to use a specific type of virus that infects bacteria called a phage. The phage is a highly complex structure that is very long and thing. The advantage of the phage is that it can be genetically altered to bind to the antibody reagents used in current assays. We have also shown that these phage can be detected by the way in which it absorbs a certain type of polarised light. This effect is only observed when phage are aligned in solution. (Much like the way spaghetti lines up when it is stirred in a saucepan). We have shown that if something else sticks to the phage then the phage no longer aligns and we cannot detect it anymore. This means that if our phage-antibody particles bind to a germ or hormone our system will detect its presence.So why will this help simplify assays? Our assay will require only the simple addition of the phage-antibody to the sample. This is compared to the existing system that requires at least 3 reagents to be added requiring a specialist scientist. Then in our system it is a simple task to read the result using a simple instrument. The complete assay procedure would take &amp;lt;5 minutes which is extremely rapid compared to the current systems which can take hours.This makes it possible for the assay system to be used in GP surgeries or directly on the clinical ward. Finally the system uses antibodies that have already been developed for the existing assays meaning that all currently available tests can be used immediately with this new detection system.Taken together the phage-antibody detection system will help improve diagnosis and control of disease for a wide range of patients.</gtr:abstractText><gtr:fund><gtr:end>2009-11-16</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-11-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>102375</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Defence Science &amp; Technology Laboratory (DSTL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of Bioassays (dstl)</gtr:description><gtr:id>72D718AF-DF39-4B0B-A2AE-F34F8B41A29F</gtr:id><gtr:impact>confidential</gtr:impact><gtr:outcomeId>545ccfcd14fc38.33104971-1</gtr:outcomeId><gtr:partnerContribution>confidential</gtr:partnerContribution><gtr:piContribution>confidential</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Appearence on TV</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>56678295-3645-45ED-884A-D94A44EDB863</gtr:id><gtr:impact>Unknown

Increased public exposure for Synthetic Biology</gtr:impact><gtr:outcomeId>545cd501db0b40.60194481</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A molecular sensor (10) comprises a flow path (12) configured for flowing a solution (28) potentially containing a target molecule (26). A source of polarised light (16) is provided and a detector (18) arranged to receive light from the source after it has passed through the flow path. A sensor element (19) is provided comprising a scaffold moiety (20) with a high aspect ratio disposed, in use, within the flow path and a receptor moiety (24), for the target molecule, attached to the scaffold moiety. A method for sensing a target molecule in a flowing solution is also described.</gtr:description><gtr:grantRef>EP/G005869/1</gtr:grantRef><gtr:id>90FB5364-D713-47AB-96B5-BF25CA008997</gtr:id><gtr:impact>Basis for Spinout</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>m-1944341232.948323766a5ec4</gtr:outcomeId><gtr:patentId>WO2008059280</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>MOLECULAR DETECTION SYSTEM</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The invention provides light-emitting compositions, including lasing and fluorescent compositions. The invention particularly relates to programmable biological substrates, which fluoresce and/or lase, and which have a wide variety of different applications. The invention extends to use of the fluorescent compositions and lasing compositions comprising programmable biological substrates in fabricating lasers, and in various biological imaging applications, such as in assays.</gtr:description><gtr:grantRef>EP/G005869/1</gtr:grantRef><gtr:id>16BDD547-F890-4D49-839A-54D1910660A8</gtr:id><gtr:impact>Viral laser</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>545cd859a239c1.82103284</gtr:outcomeId><gtr:patentId>WO2013093499</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>A COMPOSITION</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair of Policy Committee - Biochemical Soceity</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>64779963-ABAF-4888-B5DE-7EB40DA0B4D3</gtr:id><gtr:impact>The policy committee at BS makes recommendations on a range of issues related to Biochemistry</gtr:impact><gtr:outcomeId>545cd64be17773.96395844</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointment to Entrepreneur in Residence for SynBio at BIS</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E5D037A7-552E-4E94-87E5-A3BA088D005A</gtr:id><gtr:outcomeId>545cd59e2d1da1.65264878</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the Uk Synthetic Biology Leadership Council</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C3FAED8-8965-46F5-B939-A5EE17886BBE</gtr:id><gtr:impact>The SBLC is a ministerial committee charged with the development of a Synthetic Biology within the UK</gtr:impact><gtr:outcomeId>545cdd068e90f1.63971382</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The worlds first linear dichroism instrument customised for use with biological samples</gtr:description><gtr:id>EA39037F-57D9-4397-B6B7-3B6BDD488D09</gtr:id><gtr:impact>Has led to new insights into the behaviour of DNA, membrane proteins and protein fibres</gtr:impact><gtr:outcomeId>0D95B4F8077</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Linear Dichroism Instrument</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Linear Diagnostics Ltd</gtr:companyName><gtr:description>Diagnostics company specialising in Agri/medical and defense applications</gtr:description><gtr:id>5B3925CB-5CE7-4F7B-9A8E-BB8CA77B0D21</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>545cd96cc2bc66.42249364</gtr:outcomeId><gtr:yearCompanyFormed>2012</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>2765C727-A380-497A-B675-E3D7AC738CFC</gtr:id><gtr:title>Linear and Circular Dichroism</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dcc980562e0e1eb2f851192efd50500"><gtr:id>4dcc980562e0e1eb2f851192efd50500</gtr:id><gtr:otherNames>A Rodger</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>m_320231623413aa6fe6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC3935DF-0DD3-49D7-9B43-EE92479A4E34</gtr:id><gtr:title>Detection of pathogenic bacteria using a homogeneous immunoassay based on shear alignment of virus particles and linear dichroism.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1fcf57b543faa1b6e3acc14be34377"><gtr:id>bb1fcf57b543faa1b6e3acc14be34377</gtr:id><gtr:otherNames>Pacheco-G?mez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>545ccd79eb6050.83631894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA99F49C-AD1A-400C-96AE-6979FB85CFAD</gtr:id><gtr:title>Polymerase Chain Reaction on a Viral Nanoparticle.</gtr:title><gtr:parentPublicationTitle>ACS synthetic biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/754d6d7257781e5776365594bb8bc0e1"><gtr:id>754d6d7257781e5776365594bb8bc0e1</gtr:id><gtr:otherNames>Carr-Smith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2161-5063</gtr:issn><gtr:outcomeId>56cc35d59a1786.03370801</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G005869/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>98EA7556-1427-44F9-84F3-BF99B7207302</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Analytical Science</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>